Literature review · Sexual & reproductive health / Cognition & mood

Oxytocin

A neuropeptide studied in social processing, relationships and sexual function. Laboratory signals of partner-related responses have not translated into a dependable general claim that a supplied product improves intimacy, relationships or mental health.

By HeartPep · Reviewed · 7 selected source records

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

At a glance

The selected evidence includes small partner-related experiments, a sexual-function placebo comparison, a larger autism trial and registered trust-game replications. The latter challenge a simple claim that oxytocin reliably increases trust.

Identity & scope

This dossier covers the catalogue name Oxytocin. The studied clinical preparations and the supplier's listed material are not assumed to have the same formulation, exposure or manufacturing quality.

Catalogue labels covered: Oxytocin.

What the research shows

  • Two small experiments reported partner-specific attractiveness ratings and reward-region imaging responses in pair-bonded men.
  • A sexual-function crossover trial found improvement over time in both oxytocin and placebo conditions, without a significant treatment difference.
  • A larger autism trial did not find a significant advantage on its main social-function outcome. This is a different population and question, not a test of couples' relationships.
  • Registered trust-game replications did not confirm a general increase in trusting behaviour; the 2026 pooled analysis includes the earlier 2020 cohort and must not be counted as wholly independent evidence.

Critical interpretation

Replication narrows a broad trust narrative

The registered replications test a more specific proposition than whether oxytocin has any social effect. Their results weaken a general trust-increasing claim under the studied conditions. The 2026 pooled analysis also provides more precise evidence about the size of a possible effect, while depending partly on the 2020 dataset rather than supplying a third independent replication. [4] [5]

A substantial null clinical result still has boundaries

The larger autism trial found no treatment advantage, including in sensitivity analyses. Its full report also notes uncertainty about its modified primary scale and preparation-dependent absorption. Those limitations help define what was tested; they do not turn a null result into proof of effectiveness. Equally, this clinical study cannot determine whether every social context or another precisely defined outcome is unaffected. [3]

Laboratory attraction is not a relationship outcome

The small partner-face experiments examine ratings and neural responses. They do not demonstrate lasting trust, improved conflict resolution or healthier relationships. Those outcomes would require direct study rather than extrapolation from a scan. [1]

Saliva is a separate measurement question

The validated procedure addresses how to measure oxytocin in a particular specimen. Salivary concentration cannot by itself explain social behaviour, central exposure or responses to a nasal preparation. [6]

Limitations & uncertainties

  • Brain responses and laboratory ratings do not establish lasting relationship change or clinical effectiveness.
  • Results in selected men, women with sexual dysfunction or autistic children cannot be generalized across populations.
  • None of these studies validates catalogue batch quality, a particular supplied format or personal use.

Open research questions

  • Which reproducible outcomes, if any, depend on population and social context?
  • Can well-controlled replication connect laboratory effects with meaningful longer-term outcomes?

Selected papers & source records

Download bibliography
Human studyNamed compoundAbstract / record checked

1. Oxytocin enhances brain reward system responses in men viewing the face of their female partner (opens in a new tab)

Scheele D et al. (2013). Proc Natl Acad Sci U S A. DOI: 10.1073/pnas.1314190110 (opens in a new tab) · PMID 24277856

Design & population
Two double-blind placebo-controlled within-person fMRI experiments, each involving 20 pair-bonded men.
What the study found
Partner-face ratings and selected reward-region responses increased relative to comparison faces.
Limits on interpretation
Small, selected population and laboratory endpoints; no durable relationship outcome established.
Human studyNamed compoundAbstract / record checked

2. Effect of long-term intranasal oxytocin on sexual dysfunction in premenopausal and postmenopausal women: a randomized trial (opens in a new tab)

Muin DA et al. (2015). Fertil Steril. DOI: 10.1016/j.fertnstert.2015.06.010 (opens in a new tab) · PMID 26151620

Design & population
Randomized double-blind placebo-controlled crossover trial in 30 women with sexual dysfunction.
What the study found
Both conditions improved over time, with no significant treatment difference in the reported analyses.
Limits on interpretation
Small clinical population; improvement cannot be attributed to oxytocin over placebo.
Human studyNamed compoundFull text consulted

3. Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder (opens in a new tab)

Sikich L et al. (2021). N Engl J Med. DOI: 10.1056/NEJMoa2103583 (opens in a new tab) · PMID 34644471

Design & population
Randomized placebo-controlled 24-week trial enrolling 290 children and adolescents with autism.
What the study found
The primary social-function comparison was not significant; secondary results were generally similar between groups.
Limits on interpretation
The modified primary scale was not validated and formulation-dependent exposure remained uncertain; sensitivity analyses were also negative. Not a study of adult intimacy.
Human studyNamed compoundAbstract / record checked

4. A registered replication study on oxytocin and trust (opens in a new tab)

Declerck CH et al. (2020). Nat Hum Behav. DOI: 10.1038/s41562-020-0878-x (opens in a new tab) · PMID 32514040

Design & population
Large double-blind placebo-controlled registered replication of a trust-game experiment, including minimal-social-contact and no-contact conditions.
What the study found
No oxytocin effect was found in the planned minimal-social-contact condition; an exploratory subgroup observation required confirmation.
Limits on interpretation
Economic-game transfers are a specific behavioural endpoint, not a general measure of intimacy, relationship health or all social behaviour.
Human studyNamed compoundAbstract / record checked

5. Absence of a meaningful effect of intranasal oxytocin on trusting behavior: a registered report with pooled equivalence testing (opens in a new tab)

Kroll CF et al. (2026). Cortex. DOI: 10.1016/j.cortex.2026.03.006 (opens in a new tab) · PMID 41880977

Design & population
Registered replication in 211 participants plus pooled analysis with the 321-participant Declerck dataset.
What the study found
No increased trust was identified. Pooled equivalence testing in 532 participants supported an effect within the study's predefined small range.
Limits on interpretation
The pooled analysis reuses the 2020 participants and is not an independent additional cohort. Conclusions are specific to this task and equivalence margin.
Chemical analysisNamed compoundAbstract / record checked

6. A UHPLC-MS/MS method for the quantification of oxytocin in human saliva (opens in a new tab)

Soloperto S, Mula J, Chiara F, et al. (2026). Psychoneuroendocrinology. DOI: 10.1016/j.psyneuen.2026.108078 (opens in a new tab) · PMID 42998617

Design & population
Analytical method validation for oxytocin quantification in human saliva using UHPLC–tandem mass spectrometry, including application to human samples.
What the study found
The authors reported usable measurements from collected saliva samples, with greater variability at low concentrations.
Limits on interpretation
Abstract consulted. Assay performance applies to the studied sample matrix. The study did not establish a saliva-to-brain relationship or a treatment effect.
Human studyNamed compoundAbstract / record checked

7. Preoperative Intranasal Oxytocin and Probable Acute Stress Disorder After Traumatic Fracture Surgery: A Randomized Clinical Trial (opens in a new tab)

Huang Q et al. (2026). JAMA Internal Medicine. DOI: 10.1001/jamainternmed.2026.5326 (opens in a new tab) · PMID 42931765

Design & population
Single-centre randomized clinical trial in adults undergoing traumatic-fracture surgery.
What the study found
Fewer participants in the oxytocin group screened positive for probable acute stress disorder during early postoperative follow-up.
Limits on interpretation
The screening result was not a diagnostic assessment. The trial does not establish longer-term outcomes, generalizability, or applicability to a catalogue product.

Search & review scope

Targeted PubMed-domain searches and original abstract checks, including controlled negative findings alongside laboratory social-response studies. Initial selection on 8 November was substantively extended on 9 November, with clinical searches, accessible full-text consultation and bounded publication-notice checks. Added a targeted November 2026 analytical source check. Also checked newly indexed or previously omitted original abstracts and identifiers.. Checked 20 November 2026.

Selected sexual/social human experiments, a larger clinical autism trial and registered trust-game replication evidence including a 2026 pooled analysis. Checked the PubMed abstract and DOI for the salivary oxytocin assay. Added selected human study records dated 2026, with study-specific limitations.

Not exhaustive. Full methods, results and limitations of PMID34644471 were consulted in PMC; other included studies remain abstract-verified. Nature subscription content and ScienceDirect access limits prevented full appraisal of the trust papers. Its complete retrieved PubMed record showed no linked retraction/erratum section; incomplete retrieval limited other notice checks. The new analytical source was reviewed at abstract level.

Recorded search terms
  • site:pubmed.ncbi.nlm.nih.gov oxytocin 26151620 24277856
  • site:pubmed.ncbi.nlm.nih.gov/26151620/
  • site:pubmed.ncbi.nlm.nih.gov/24277856/
  • site:pubmed.ncbi.nlm.nih.gov oxytocin autism randomized trial 2021 Sikich
  • site:pubmed.ncbi.nlm.nih.gov oxytocin registered replication trust placebo large trial
  • "A registered replication study on oxytocin and trust" correction
  • site:sciencedirect.com "10.1016/j.cortex.2026.03.006"
  • PMID 42998617 / DOI 10.1016/j.psyneuen.2026.108078
  • PMID 42931765 / DOI 10.1001/jamainternmed.2026.5326

Read the collection’s methods and editorial limits. For formal research, assess and cite the original paper.

Cite this review

HeartPep. Oxytocin: literature review. HeartPep literature library. Reviewed 20 November 2026. https://heartpep.com/uk/research/library/oxytocin.

HeartPep is the commercial publisher of this secondary summary. It is not a peer-reviewed primary paper. Cite the original studies for their findings.

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

← All reviews and reference notes